Kilitch Drugs India Closes Trading Window for Insider Trading

Kilitch Drugs India Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is effective from July 1, 2026, and will remain in effect for designated persons and their immediate relatives until 48 hours after the declaration of the financial results for the quarter ended June 30, 2026. The specific date for the Board of Directors' meeting to approve these unaudited financial results will be communicated later. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, aimed at preventing potential insider trading.